Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-02-27

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a generic irinotecan hydrochloride product under ANDA 077776 from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)